Format

Send to

Choose Destination
See comment in PubMed Commons below
Phys Med Rehabil Clin N Am. 2008 Aug;19(3):461-77, viii. doi: 10.1016/j.pmr.2008.04.001.

Current and future directions in genomics of amyotrophic lateral sclerosis.

Author information

1
Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA 98101, USA. jravits@benaroyaresearch.org

Abstract

New knowledge of the structure and function of the human genome and novel genomic technologies are being applied to the study of sporadic amyotrophic lateral sclerosis (ALS). These studies can examine tens to hundreds of thousands of items at once, and depend on sophisticated computer processing. Current studies are focused on genetic susceptibility and gene expression and future studies will likely focus on structural variation, gene regulation and non-protein coding regions. The hope is that they will lead to deeper understanding of molecular aspects of the disease and to rational therapeutic targets.

PMID:
18625410
PMCID:
PMC3524513
DOI:
10.1016/j.pmr.2008.04.001
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center